Paper39488607
Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia.
Mack T and 5 others. Sci Rep, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia. Papers, record 39488607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39488607
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Cell Line, Tumor | |
| Gene Expression Profiling | |
| Real-Time Polymerase Chain Reaction | |
| Gene Expression Regulation, Leukemic | |
| Reference Standards |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29570994 | Metazoan MicroRNAs. | Cell | 2018 | https://conductscience.org/library/papers/29570994 | PubMed |
| 2 | 24275495 | miRBase: annotating high confidence microRNAs using deep sequencing data. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/24275495 | PubMed |
| 3 | 32855905 | Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review. | World J Clin Oncol | 2020 | https://conductscience.org/library/papers/32855905 | PubMed |
| 4 | 22412151 | Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22412151 | PubMed |
| 5 | 34442359 | Targeted Therapy in Acute Lymphoblastic Leukaemia. | J Pers Med | 2021 | https://conductscience.org/library/papers/34442359 | PubMed |
| 6 | 18818707 | Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. | Leukemia | 2008 | https://conductscience.org/library/papers/18818707 | PubMed |
| 7 | 31737072 | The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy. | J Oncol | 2019 | https://conductscience.org/library/papers/31737072 | PubMed |
| 8 | 38127276 | RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. | Blood Adv | 2024 | https://conductscience.org/library/papers/38127276 | PubMed |
| 9 | 34098582 | MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia. | Blood | 2021 | https://conductscience.org/library/papers/34098582 | PubMed |
| 10 | 24280866 | Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia. | Leukemia | 2014 | https://conductscience.org/library/papers/24280866 | PubMed |
| 11 | 20360395 | Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. | RNA | 2010 | https://conductscience.org/library/papers/20360395 | PubMed |
| 12 | 19436744 | Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. | PLoS One | 2009 | https://conductscience.org/library/papers/19436744 | PubMed |
| 13 | 19246619 | The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. | Clin Chem | 2009 | https://conductscience.org/library/papers/19246619 | PubMed |
| 14 | 36291806 | Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291806 | PubMed |
| 15 | 22088964 | Diversity of human leukemia xenograft mouse models: implications for disease biology. | Cancer Res | 2011 | https://conductscience.org/library/papers/22088964 | PubMed |
| 16 | 21295523 | Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways. | Cancer Cell | 2011 | https://conductscience.org/library/papers/21295523 | PubMed |
| 17 | 28550041 | Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor. | Blood | 2017 | https://conductscience.org/library/papers/28550041 | PubMed |
| 18 | 30389682 | PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia. | EMBO Mol Med | 2018 | https://conductscience.org/library/papers/30389682 | PubMed |
| 19 | 31693904 | Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. | Cell Rep | 2019 | https://conductscience.org/library/papers/31693904 | PubMed |
| 20 | 33722259 | PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33722259 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42123456 | Differential Expression and Target Gene Analysis of PBMC-Derived microRNAs as Prognostic Biomarkers in Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123456 | PubMed |
| 41483090 | A systematic review of MicroRNA (miRNA) biomarkers in the diagnosis and prognosis of hepatocellular carcinoma. | Ir J Med Sci | 2026 | https://conductscience.org/library/papers/41483090 | PubMed |
| 40800069 | Pre-analytical considerations for microRNA quantification in childhood leukemia research. | J Biol Methods | 2025 | https://conductscience.org/library/papers/40800069 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| RNU1-1 | 26871 | PubTator's text mining | https://conductscience.org/library/genes/26871 | NCBI Gene |
| RNU6-1 | 26827 | PubTator's text mining | https://conductscience.org/library/genes/26827 | NCBI Gene |
| SNORD44 | 26806 | PubTator's text mining | https://conductscience.org/library/genes/26806 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39488607
GET https://conductscience.org/api/papers/v1/39488607/references?page=2